Central Trust Company’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.67M | Sell |
308,862
-5,626
| -2% | -$150K | 0.17% | 96 |
|
|
2025
Q4 | $7.83M | Sell |
314,488
-85,365
| -21% | -$2.15M | 0.15% | 102 |
|
|
2025
Q3 | $10.2M | Sell |
399,853
-54,685
| -12% | -$1.35M | 0.21% | 82 |
|
|
2025
Q2 | $11M | Buy |
454,538
+23,044
| +5% | +$537K | 0.25% | 67 |
|
|
2025
Q1 | $10.9M | Buy |
431,494
+36,044
| +9% | +$943K | 0.27% | 69 |
|
|
2024
Q4 | $10.5M | Sell |
395,450
-68,310
| -15% | -$1.85M | 0.26% | 70 |
|
|
2024
Q3 | $13.4M | Sell |
463,760
-6,827
| -1% | -$199K | 0.31% | 66 |
|
|
2024
Q2 | $13.2M | Sell |
470,587
-7,887
| -2% | -$217K | 0.32% | 63 |
|
|
2024
Q1 | $13.3M | Sell |
478,474
-24,296
| -5% | -$674K | 0.33% | 61 |
|
|
2023
Q4 | $14.5M | Sell |
502,770
-26,168
| -5% | -$791K | 0.38% | 53 |
|
|
2023
Q3 | $17.5M | Sell |
528,938
-20,581
| -4% | -$728K | 0.51% | 42 |
|
|
2023
Q2 | $20.2M | Sell |
549,519
-1,656
| -0.3% | -$64.5K | 0.56% | 41 |
|
|
2023
Q1 | $22.5M | Sell |
551,175
-2,557
| -0.5% | -$110K | 0.66% | 38 |
|
|
2022
Q4 | $28.4M | Sell |
553,732
-9,240
| -2% | -$443K | 0.87% | 31 |
|
|
2022
Q3 | $24.6M | Sell |
562,972
-4,508
| -0.8% | -$219K | 0.84% | 31 |
|
|
2022
Q2 | $29.8M | Buy |
567,480
+5,156
| +0.9% | +$263K | 0.98% | 25 |
|
|
2022
Q1 | $29.1M | Sell |
562,324
-12,903
| -2% | -$669K | 0.83% | 30 |
|
|
2021
Q4 | $34M | Sell |
575,227
-5,402
| -0.9% | -$268K | 0.96% | 22 |
|
|
2021
Q3 | $25M | Sell |
580,629
-984
| -0.2% | -$43.6K | 0.89% | 26 |
|
|
2021
Q2 | $22.8M | Sell |
581,613
-4,685
| -0.8% | -$182K | 0.83% | 25 |
|
|
2021
Q1 | $21.2M | Sell |
586,298
-8,800
| -1% | -$312K | 0.83% | 26 |
|
|
2020
Q4 | $21.9M | Sell |
595,098
-31,141
| -5% | -$1.14M | 0.9% | 24 |
|
|
2020
Q3 | $21.8M | Buy |
626,239
+26,168
| +4% | +$917K | 0.99% | 20 |
|
|
2020
Q2 | $18.6M | Buy |
600,071
+7,513
| +1% | +$255K | 0.93% | 23 |
|
|
2020
Q1 | $18.4M | Buy |
592,558
+12,616
| +2% | +$430K | 1.12% | 18 |
|
|
2019
Q4 | $21.6M | Sell |
579,942
-5,616
| -1% | -$200K | 1.1% | 21 |
|
|
2019
Q3 | $20M | Sell |
585,558
-32,146
| -5% | -$1.17M | 1.12% | 20 |
|
|
2019
Q2 | $25.2M | Sell |
617,704
-13,936
| -2% | -$553K | 1.43% | 16 |
|
|
2019
Q1 | $25.5M | Sell |
631,640
-1,096
| -0.2% | -$43.9K | 1.52% | 13 |
|
|
2018
Q4 | $26.2M | Sell |
632,736
-5,928
| -0.9% | -$246K | 1.74% | 6 |
|
|
2018
Q3 | $26.7M | Sell |
638,664
-2,206
| -0.3% | -$84.9K | 1.55% | 10 |
|
|
2018
Q2 | $22.1M | Sell |
640,870
-2,562
| -0.4% | -$87.6K | 1.41% | 15 |
|
|
2018
Q1 | $21.7M | Sell |
643,432
-8,403
| -1% | -$289K | 1.38% | 14 |
|
|
2017
Q4 | $22.4M | Sell |
651,835
-8,970
| -1% | -$306K | 1.36% | 14 |
|
|
2017
Q3 | $22.4M | Buy |
660,805
+1,509
| +0.2% | +$48.5K | 1.45% | 13 |
|
|
2017
Q2 | $21M | Sell |
659,296
-52,177
| -7% | -$1.65M | 1.39% | 12 |
|
|
2017
Q1 | $23.1M | Sell |
711,473
-21,671
| -3% | -$683K | 1.54% | 8 |
|
|
2016
Q4 | $22.6M | Sell |
733,144
-14,201
| -2% | -$434K | 1.56% | 10 |
|
|
2016
Q3 | $24M | Buy |
747,345
+35,980
| +5% | +$1.2M | 1.75% | 5 |
|
|
2016
Q2 | $23.8M | Buy |
711,365
+4,510
| +0.6% | +$144K | 1.78% | 6 |
|
|
2016
Q1 | $19.9M | Buy |
706,855
+28,944
| +4% | +$827K | 1.57% | 8 |
|
|
2015
Q4 | $20.8M | Sell |
677,911
-13,290
| -2% | -$418K | 1.71% | 7 |
|
|
2015
Q3 | $20.6M | Buy |
691,201
+817
| +0.1% | +$26.2K | 1.79% | 5 |
|
|
2015
Q2 | $22M | Buy |
690,384
+12,501
| +2% | +$407K | 1.73% | 4 |
|
|
2015
Q1 | $22.4M | Buy |
677,883
+55,142
| +9% | +$1.75M | 1.8% | 6 |
|
|
2014
Q4 | $18.4M | Sell |
622,741
-20,878
| -3% | -$599K | 1.5% | 11 |
|
|
2014
Q3 | $18.1M | Sell |
643,619
-26,160
| -4% | -$734K | 1.43% | 10 |
|
|
2014
Q2 | $18.9M | Buy |
669,779
+13,846
| +2% | +$395K | 1.49% | 10 |
|
|
2014
Q1 | $20M | Buy |
655,933
+38,919
| +6% | +$1.16M | 1.65% | 10 |
|
|
2013
Q4 | $17.9M | Sell |
617,014
-41,267
| -6% | -$1.2M | 1.5% | 10 |
|
|
2013
Q3 | $17.9M | Buy |
658,281
+15,616
| +2% | +$425K | 1.62% | 9 |
|
|
2013
Q2 | $17.1M | Buy |
+642,665
| New | +$17.8M | 1.62% | 12 |
|
Other funds holding PFE
VCM
VPM
Central Trust Company's PFE Position: Q1 2026 in Review
Central Trust Company reduced its Pfizer (PFE) stake by 1.8% in Q1 2026, selling an estimated $150K and leaving 308,862 shares worth $8.67M. The position accounts for 0.17% of the portfolio, ranked #96.
Central Trust Company first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $34M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Central Trust Company held 308,862 shares of Pfizer worth $8.67M as of Q1 2026.
- Central Trust Company sold 5,626 Pfizer shares in Q1 2026, an estimated $150K.
- Pfizer made up 0.17% of Central Trust Company's portfolio in Q1 2026, its #96 holding.
- Central Trust Company first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Central Trust Company's Pfizer position peaked at $34M in Q4 2021.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Central Trust Company's 13F filing for Q1 2026, filed 17 Apr 2026.